NLRP3 and acute kidney injury: For instance, targeting GPx‐1/NLRP3/Caspase‐1 pathway, Wang et al.[123] fabricated selenium‐bovine serum albumin nanoparticles (Se@BSA NPs) and assessed their mitigative effects on AKI.